RE: Time to Re-Assess9 Oct 2020 15:33
"Where UK-RTC are concerned, irrespective of what the test is sold for be it £10 (if that the price to Government) or £20, £30, or whatever (privately) where the final selling price is greater than the aggregated costs then the profit will be shared equally amongst the 4 consortium members."
That was not what has been said in the various presentations. However, now that the MoU has come to an end and a new agreement is being put in place, the income distribution structure may change.
The fundamental point remains that we are part of a consortium. We will effectively remain as additional manufacturing capacity for the lead organisation (Abingdon Health) and the sales/distribution is being led and managed by CIGA on behalf of the consortium.